We are live on ! Find out more

429 hedge funds and large institutions have $6.34B invested in Chemed in 2022 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 135 increasing their positions, 172 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $610K

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

31% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 36

1% more funds holding

Funds holding: 425429 (+4)

0.32% more ownership

Funds ownership: 89.83%90.15% (+0.32%)

7% less capital invested

Capital invested by funds: $6.79B → $6.34B (-$450M)

22% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 172

Holders
429
Holders Change
+4
Holders Change %
+0.94%
% of All Funds
7.23%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
47
Increased
135
Reduced
172
Closed
36
Calls
$3.57M
Puts
$610K
Net Calls
+$2.96M
Net Calls Change
-$3.17M

CHE Hedge Fund Activity: Q2 2022 in Review

429 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q2 2022, worth a combined $6.34B — down 6.6% from $6.79B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new CHE positions and 36 closed out — a net gain of 11 holders — while 135 added to existing stakes and 172 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $82.9M. The largest seller was Janus Henderson Group, cutting an estimated $38M.

  • 429 institutional investors held Chemed (CHE) as of Q2 2022, up from 425 in Q1 2022.
  • Funds reported $6.34B of Chemed stock for Q2 2022, down 6.6% quarter-over-quarter.
  • 47 funds opened new Chemed positions in Q2 2022 and 36 closed out, a net change of +11 holders.
  • The largest Chemed buyer in Q2 2022 was Victory Capital Management, an estimated $82.9M added.
  • The largest Chemed seller in Q2 2022 was Janus Henderson Group, an estimated $38M sold.

Based on aggregated 13F filings for Q2 2022.